全文获取类型
收费全文 | 15676篇 |
免费 | 1400篇 |
国内免费 | 65篇 |
专业分类
耳鼻咽喉 | 205篇 |
儿科学 | 351篇 |
妇产科学 | 231篇 |
基础医学 | 2050篇 |
口腔科学 | 220篇 |
临床医学 | 1709篇 |
内科学 | 3356篇 |
皮肤病学 | 380篇 |
神经病学 | 949篇 |
特种医学 | 651篇 |
外科学 | 2639篇 |
综合类 | 115篇 |
现状与发展 | 1篇 |
一般理论 | 5篇 |
预防医学 | 1317篇 |
眼科学 | 543篇 |
药学 | 1137篇 |
中国医学 | 85篇 |
肿瘤学 | 1197篇 |
出版年
2024年 | 14篇 |
2023年 | 156篇 |
2022年 | 358篇 |
2021年 | 846篇 |
2020年 | 458篇 |
2019年 | 562篇 |
2018年 | 654篇 |
2017年 | 431篇 |
2016年 | 521篇 |
2015年 | 526篇 |
2014年 | 665篇 |
2013年 | 718篇 |
2012年 | 1145篇 |
2011年 | 1111篇 |
2010年 | 650篇 |
2009年 | 525篇 |
2008年 | 916篇 |
2007年 | 895篇 |
2006年 | 763篇 |
2005年 | 715篇 |
2004年 | 629篇 |
2003年 | 548篇 |
2002年 | 508篇 |
2001年 | 500篇 |
2000年 | 454篇 |
1999年 | 375篇 |
1998年 | 120篇 |
1997年 | 102篇 |
1996年 | 89篇 |
1995年 | 75篇 |
1994年 | 69篇 |
1993年 | 59篇 |
1992年 | 150篇 |
1991年 | 105篇 |
1990年 | 119篇 |
1989年 | 112篇 |
1988年 | 93篇 |
1987年 | 80篇 |
1986年 | 68篇 |
1985年 | 59篇 |
1984年 | 50篇 |
1983年 | 32篇 |
1982年 | 19篇 |
1981年 | 11篇 |
1980年 | 14篇 |
1979年 | 15篇 |
1978年 | 6篇 |
1977年 | 10篇 |
1976年 | 8篇 |
1975年 | 7篇 |
排序方式: 共有10000条查询结果,搜索用时 703 毫秒
991.
Opinion statement Therapy for basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) does not end with treatment of the initial lesion
because almost 50% of patients with one nonmelanoma skin cancer (NMSC) develop another NMSC in the next 5 years. An integrated
program of skin cancer awareness, sun protection, and prophylactic approaches is critical. The risk profile of the tumor influences
which therapies and specialties will be involved. Most NMSCs may be treated with outpatient methods. Primary care physicians
may treat low-risk tumors, but dermatologists specially trained in cutaneous oncology and a multidisciplinary team should
manage high-risk lesions. Superficial BCC and SCC may be treated adequately with superficial modalities such as electrodesiccation
and curettage (EDC) and cryotherapy. Topical 5-fluorouracil is effective for small in situ lesions. Invasive but low-risk
lesions may be treated with EDC and cryotherapy provided that the tumor is limited to the papillary dermis, is not recurrent,
and does not have high-risk features. High-risk tumors are best treated with excision and histologic examination or Mohs micrographic
surgery (MMS). MMS is the therapeutic gold standard for all NMSCs in terms of cure rates, margin control, and tissue conservation.
Because of its higher cost and specialized process, MMS is best reserved for specific indications. 相似文献
992.
Campath-1H is effective therapy for patients with relapsed and refractory chronic lymphocytic leukemia (CLL) and prolymphocytic leukemia (PLL), but it is associated with profound lymphopenia and deficiencies in cell-mediated immunity. We report the incidence of cytomegalovirus (CMV) viremia in 34 patients treated with Campath-1H for relapsed or refractory CLL and PLL. All patients received infection prophylaxis during therapy and continuing for at least 2 months following Campath-1H. Five patients (15%) developed CMV viremia at a median of 28 days (range, 20-30 days) after the first dose of Campath-1H. The median CMV viral load was 860/mL (range, 420-2100/mL), as determined by quantitative plasma polymerase chain reaction (PCR). All 5 patients had a temperature > 38.5 degrees C, normal chest radiographs, normal liver function tests, and negative bacterial blood cultures with no clinical evidence of CMV disease at the time of presentation with CMV viremia. The median absolute neutrophil count (ANC) was 740/ microL (range, 340-1600/ microL), and the median absolute lymphocyte count (ALC) was 16/microL (range, 11-169/ microL) for the 5 patients at the time of CMV viremia. All 5 patients received ganciclovir therapy followed by prompt fever resolution and clearance of CMV viremia by plasma PCR. By univariate regression analysis, the following were not risk factors for CMV viremia: age, number of prior regimens, prior rituximab therapy, prior splenectomy, modified Rai stage at Campath-1H therapy (low/intermediate vs. high), ANC, and ALC; although, there was a trend towards significance for prior rituximab therapy (P = 0.07). Cytomegalovirus viremia may be a significant infectious complication during Campath-1H therapy and should be investigated further in future studies. 相似文献
993.
BACKGROUND: The prognosis of patients with recurrent tumors of the head and neck generally is considered poor. Better prediction of outcomes can help physicians counsel patients about the merits of additional treatment. The TNM system, which was created for patients with primary tumors, may not provide optimal information. Anatomic staging systems traditionally have ignored symptom-based variables, such as weight loss, despite their known prognostic value. The objectives of this study were 1) to measure the prognostic impact of weight loss, 2) to evaluate the prognostic value of the TNM staging system, and 3) to create a practical staging system capable of predicting survival after patients develop recurrent tumors of the oral cavity and oropharynx. METHODS: A retrospective chart review was used to identify an inception cohort of patients seeking treatment for recurrent, persistent, and second primary tumors of the oral cavity and oropharynx at the University of Washington. The primary outcome variable was 1-year survival. RESULTS: The 1-year survival rate for the cohort (n = 97 patients) was 38%, with a median survival of 0.7 years. Multivariate analysis (Cox regression) identified weight loss, previous radiation to the head and neck, and TNM stage of the recurrent tumor as factors that had a substantial impact on mortality. A second multivariate technique called conjunctive consolidation was used to determine the relative quantitative impact of each variable on survival and to develop a clinical staging system. Weight loss and previous radiation had the greatest influence, and the use of just these two variables resulted in a three-tiered staging system with 1-year survival rates of 62% (16 of 26 patients), 44% (18 of 41 patients), and 10% (3 of 30 patients). In contrast, the TNM staging system produced survival rates of 60% (patients with Stage I disease), 67% (patients with Stage II disease), 32% (patients with Stage III disease), and 32% (patients with Stage IV disease). CONCLUSIONS: The authors found substantial variation in survival after patients developed recurrent tumors of the oral cavity and oropharynx. Two readily available clinical variables--weight loss and previous radiation--were combined to create a clinically practical staging scheme with more prognostic power than the TNM staging system. Until molecular markers can reliably used be to predict outcomes, greater attention needs to be given to the utility of simple, inexpensive, and surprisingly powerful clinical variables. 相似文献
994.
Banskota AH Usia T Tezuka Y Kouda K Nguyen NT Kadota S 《Journal of natural products》2002,65(11):1700-1702
Three new C-14 oxygenated taxane-type diterpenes, hongdoushans A-C (1-3), were isolated from the wood of Taxus yunnanensis together with four known diterpenes and two lignans. The absolute stereochemistry of the 2-methylbutyryloxy group attached at C-14 of the taxane skeleton was determined to be S by GC analysis of the methyl ester of 2-methylbutyric acid obtained after alkaline hydrolysis of 1 and 4 followed by treatment with CH(2)N(2). The complete stereostructure of the known compound 2alpha,5alpha,10beta-triacetoxy-14beta-[(S)-2-methylbutyryloxy]-4(20),11-taxadiene (4) was established for the first time. The isolates obtained were evaluated for their antiproliferative activity toward murine colon 26-L5 carcinoma and human HT-1080 fibrosarcoma cell lines. 相似文献
995.
Cell division is required for de novo methylation of CpG islands in bladder cancer cells 总被引:8,自引:0,他引:8
Velicescu M Weisenberger DJ Gonzales FA Tsai YC Nguyen CT Jones PA 《Cancer research》2002,62(8):2378-2384
996.
Shariat SF Gottenger E Nguyen C Song W Kattan MW Andenoro J Wheeler TM Spencer DM Slawin KM 《Cancer research》2002,62(20):5974-5979
997.
998.
999.
BACKGROUND: Teledermatology has become more widely used, but its impact has not been clearly elucidated. We developed a teledermatology program in response to clinical need, based on the store-and-forward approach. OBJECTIVE AND METHODS: Our purpose was to evaluate the satisfaction of patient and referring physician by using telephone interview. RESULTS: Both patients and providers considered this a useful program and would recommend it to a friend or colleague. The patients were split in their overall rating of the program and its ability to treat their skin conditions. Their greatest concern was their lack of direct contact with their dermatologist. Other common concerns were waiting time and follow-up. Privacy concerns were not commonly mentioned. Providers expressed greater satisfaction than their patients. Their greatest concerns involved the inability of the program to handle the demand. CONCLUSION: The program provided a service that was valued by both patients and providers. The most common concern was the impact on the physician-patient relationship. 相似文献
1000.
Idiopathic CD4+T-cell lymphocytopenia associated with vitiligo 总被引:3,自引:0,他引:3
The syndrome of idiopathic CD4+ T lymphocytopenia (ICTL) is defined as the persistent depletion of peripheral blood CD4+ T lymphocytes below 300 cells/mm(3) or less than 20% of the total lymphocytes in the absence of either HIV infection or other known causes of immunodeficiency. To date no known viral origin has been identified. ICTL has a variable clinical course ranging from patients with minimal symptoms to those who have died from opportunistic infections. We report a case of a 32-year-old white man with a long history of vitiligo that is associated with ICTL. He also had incidental psoriasis. The correlation between ICTL and autoimmune vitiligo suggests an aberration in the immune surveillance that leads to an abnormal response of CD4+ T lymphocytes in the host. 相似文献